HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Surgical technique: Porous tantalum reconstruction for destructive nonprimary periacetabular tumors.

AbstractBACKGROUND:
Large bone loss and frequently irradiated existing bone make reconstructing metastatic and other nonprimary periacetabular tumors challenging. Although existing methods are initially successful, they may fail with time. Given the low failure rates of porous tantalum acetabular implants in other conditions with large bone loss or irradiated bone, we developed a technique to use these implants in these neoplastic cases where others might fail.
DESCRIPTION OF TECHNIQUE:
After local tumor curettage, a large uncemented tantalum shell (sometimes with tantalum augments) was fixed to remaining bone using numerous screws. When substantial medial bone loss was present, an antiprotrusio cage was placed over the top of the cup and secured to remaining ilium and ischium.
PATIENTS AND METHODS:
We retrospectively reviewed 20 patients who underwent THAs for neoplastic bone destruction with the described technique. Their mean age was 60 years (range, 22-80 years). We recorded pain and ambulatory status, pain medication use, and Harris hip scores. We assessed for progressive radiolucent lines and component migration on followup radiographs. Eleven of the 20 patients died at a mean of 17 months after surgery. The minimum followup for surviving patients was 26 months (mean, 56 months; range, 26-85 months).
RESULTS:
Harris hip scores improved from a mean 32 preoperatively to a mean 74 postoperatively. We observed no cases of progressive radiolucent lines or component migration. Complications included one perioperative death, two superficial infections, one deep vein thrombosis, and one dislocation.
CONCLUSION:
Our initial experience has made tantalum reconstruction our preferred method for dealing with major periacetabular neoplastic bone loss. Additional studies comparing this technique with alternatives are required.
LEVEL OF EVIDENCE:
Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
AuthorsFazel A Khan, Peter S Rose, Michiro Yanagisawa, David G Lewallen, Franklin H Sim
JournalClinical orthopaedics and related research (Clin Orthop Relat Res) Vol. 470 Issue 2 Pg. 594-601 (Feb 2012) ISSN: 1528-1132 [Electronic] United States
PMID21989784 (Publication Type: Journal Article)
Chemical References
  • Tantalum
Topics
  • Acetabulum (diagnostic imaging, pathology, surgery)
  • Adult
  • Aged
  • Aged, 80 and over
  • Arthralgia (etiology)
  • Arthroplasty, Replacement, Hip (adverse effects, instrumentation, methods, mortality)
  • Bone Neoplasms (diagnostic imaging, mortality, secondary, surgery)
  • Bone Screws
  • Curettage
  • Female
  • Hip Joint (diagnostic imaging, pathology, physiopathology, surgery)
  • Hip Prosthesis
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Minnesota
  • Pain Measurement
  • Pain, Postoperative (etiology)
  • Porosity
  • Prosthesis Design
  • Radiography
  • Range of Motion, Articular
  • Recovery of Function
  • Registries
  • Retrospective Studies
  • Tantalum
  • Time Factors
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: